RS
XERS icon

R Squared’s Xeris Biopharma Holdings XERS Stock Holding History

R Squared’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$80.1K Buy
+13,802
New +$91.5K 0.04% 385
2025
Q4 		– Sell
-12,709
Closed -$103K – 741
2025
Q3 		$103K Buy
+12,709
New +$84.4K 0.04% 441
2025
Q2 		– Sell
-15,730
Closed -$86.4K – 574
2025
Q1 		$86.4K Buy
15,730
+3,410
+28% +$13.8K 0.09% 235
2024
Q4 		$41.8K Buy
+12,320
New +$39.6K 0.04% 570

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

R Squared's XERS Position: Q1 2026 in Review

R Squared opened a new position in Xeris Biopharma Holdings (XERS) in Q1 2026: 13,802 shares worth $80.1K. The stake represents 0.04% of the portfolio and ranks #385 among its holdings. This is a return to the name: R Squared previously reported a position in XERS as recently as Q3 2025.

R Squared first reported a position in XERS in Q4 2024 and has held it in 4 quarters since. The position peaked at $103K in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • R Squared held 13,802 shares of Xeris Biopharma Holdings worth $80.1K as of Q1 2026.
  • Xeris Biopharma Holdings was a new R Squared position in Q1 2026.
  • Xeris Biopharma Holdings made up 0.04% of R Squared's portfolio in Q1 2026, its #385 holding.
  • R Squared first reported a position in Xeris Biopharma Holdings in Q4 2024 and has held it in 4 quarters since.
  • R Squared's Xeris Biopharma Holdings position peaked at $103K in Q3 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.